迦南智能(300880.SZ):“年產350萬台智能電能表及信息採集終端建設項目”擬延期
格隆匯12月2日丨迦南智能(300880.SZ)公佈,公司於2021年12月2日召開第二屆董事會第十三次會議、第二屆監事會第十一次會議,審議通過了《關於部分募集資金投資項目延期及新增實施主體和實施地點的議案》,同意在募集資金投資項目(“募投項目”)投資用途及投資規模不發生變更的前提下,考慮募投項目的實際進展情況,決定對“研發中心建設項目”新增實施主體和實施地點,同時延長項目的建設期;擬將“年產350萬台智能電能表及信息採集終端建設項目”達到預定可使用狀態的時間由2021年12月調整至2022年6月。此次募投項目調整,不涉及變更募投項目用途,無需提交股東大會審議批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.